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Data on FGM/C are rarely collected in health facilities (Dirisu et al., 2020; 
Johansen et al., 2018; Kimani and Okondo, 2020),  yet, routine collection of 
facility-based data on FGM/C status through other health-seeking visits (e.g., 
during antenatal care) is not only considered good medical practice (WHO, 
2018), but can be an important source of data. Clinical data on FGM/C can also 
inform efforts to manage complications (Johansen et al., 2018). As illustrated in 
Figure 1, clinical exams provide an opportunity to identify women and girls who 
have undergone FGM/C, which is an important step in aiding the prevention of 
chronic complications that can be difficult and expensive to manage later in life. 
Clinical exams also make it possible to refer those with FGM/C-related 
complications for specialised treatment. The information gathered during clinical 
exams may be more reliable as it enables the examiner to observe and confirm 
whether the woman has been cut or not, and document more detailed 
information about the different types of FGM/C. It may also reduce errors related 
to misreporting and underreporting that is common when women are asked to 
report on their experience with FGM/C. Clinical visits also present an opportunity 
to discuss prevention of the practice. In instances where women seeking asylum 
due to FGM/C are required to prove their status, physical exams can provide 
supporting evidence.  
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ABOUT THIS NOTE 
This note outlines critical considerations for collecting and documenting FGM/C data by health care 
providers. We draw on existing literature and key findings from a study conducted by the Evidence to End 
FGM/C research consortium that aimed to gather data from professionals working in the area of FGM/C 
about their views and experiences in the measurement of FGM/C prevalence (Matanda, 2020). 
 
KEY CONSIDERATIONS 
1. Health care workers need adequate 
training on FGM/C: Even though 
considered the gold standard approach in 
data collection on FGM/C (Elmusharaf et al., 
2006), findings from studies that have 
investigated the validity of physical 
examination have shown that the routine 
collection of FGM/C data may be hindered 
by several factors. First, clinicians may 
incorrectly report women's FGM/C status 
because they are rarely trained on the 
practice. Second, there is substantial 
variability in the type of FGM/C performed  
 
 
across and within countries, which can make 
it difficult to ascertain the type of FGM/C. 
Although the World Health Organization has 
developed a clinical handbook to help 
clinicians manage health complications from 
FGM/C (WHO, 2018), in many settings, 
there are no guidelines on how to conduct 
physical exams especially when dealing with 
women likely to have undergone FGM/C. 
Finally, examination is an invasive procedure 
and is likely to be traumatic to women and 
girls if handled unprofessionally—especially 
in cases where it is done without consent of 
the patient.  
 
“It is very intrusive…why should women/girls undergo unnecessary pelvic exams for 
what - documentation purposes? ... unless they are treating women for 
gynaecological check-ups or ailments or during pregnancy, I see no reason why 
health care providers should be examining anyone to report FGM/C status. You may 
find instances where girls are subjected to these physical exams without their 
consent, which can also be harmful.” - Researcher, Kenya 
2. Punitive anti-FGM/C laws can cause fear 
among FGM/C survivors and antagonise 
the relationship between health care 
providers and patients: In contexts where 
FGM/C is illegal and reporting by health care 
providers is mandatory, FGM/C survivors 
may avoid routine visits to health facilities. 
Punitive anti-FGM/C laws cause fear among 
FGM/C survivors and antagonise the 
relationship between health care providers 
and patients. In such an environment, 
FGM/C survivors are likely to develop poor 
health-seeking behaviours, especially for 
cases that involve physical examination of 
their genitals. Physical examination could 
amount to ethnic/racial profiling if the 
exercise does not apply to every woman/girl 
in a given setting. Immigrant women from 
countries that have traditionally practised 
FGM/C are in most cases specifically 
targeted for physical examinations with the 
aim of assessing their FGM/C status. This 
approach may be considered discriminatory 
as it profiles individuals based on their 
background information such as ethnicity 
and country of origin. Physical examination 
could also be a source of shame and 
discomfort among FGM/C survivors. In 
contexts where FGM/C is frowned upon, 
women who have undergone FGM/C may 
feel uncomfortable undergoing the physical 




“Probably many asymptomatic FGM survivors avoid routine visits and therefore there may be an 
overreporting of symptom prevalence. This is especially true in countries where reporting is 
mandatory, and patients know it.” - Health care provider, USA 
3. Inability of the health system to facilitate 
documentation of FGM/C can be a 
hinderance to clinical examinations: 
Health systems must offer an enabling 
environment to support the documentation of 
FGM/C by providing requisite tools for 
recording and documenting FGM/C cases; 
training health care personnel  on the 
documentation of FGM/C; and ensuring the 
availability of clear policy guidelines to 
support FGM/C-related data collection. 
Health systems must also address the 
3 
ethical challenges related to the 
documentation of FGM/C cases. These 
challenges include adherence to laws that 
require health care providers to report 
FGM/C cases while at the same time 
attending to the needs of the patient; doing 
more harm to the child by reporting FGM/C, 
which can lead to the child being separated 
from parents; making physical examination a 
requirement for accessing other benefits; 
conducting physical exams without consent 
from women; intrusion of a girl’s or woman’s 
privacy that can cause trauma especially for 
underage girls; and challenges with consent 
and implementation of physical exams 
outside a health facility setting.  
 
4. It is feasible to use images in identifying 
and classifying the different types of 
FGM/C: Given the debate around 
classification of the various types of FGM/C, 
images/pictorial presentations can help 
providers identify and classify FGM/C. 
Anatomical drawings can be very helpful in 
improving the documentation of the extent of 
FGM/C. Matanda (2020) and Abdulcadir et al 
(2016) found that images were considered 
helpful both in scenarios where the health 
care provider was expected to observe and 
record FGM/C cases, and in situations 
where a woman was shown the images to 
identify the type of FGM/C. Images are also 
useful in training health care providers about 
the anatomy of the woman’s genitalia and 
the alterations that can occur due to FGM/C. 
However, the use of images could equally 
raise ethical challenges such as respecting 
cultures that are not comfortable with public 
show of images representing what is 
considered private. Further, only showing 
photos of women from particular ethnic 
groups with extreme forms of FGM/C could 
raise ethical questions. 
 
CONCLUSION 
In recent years, there has been a marked 
increase in the amount of systematically 
collected information on FGM/C and factors 
responsible for the continuation of the practice. 
This information has been collected through a 
range of methods, including medical case 
studies, small-scale surveys and larger national 
surveys, such as the Demographic and Health 
Surveys (DHS) and Multiple Cluster Indicator 
Surveys (MICS) that include a module with 
questions on FGM/C. While national-level 
surveys, especially the DHS and MICS, have 
greatly increased understanding about the 
practice, there are important limitations. National 
surveys such as the DHS and MICS are only 
implemented about once every five years 
resulting in limited real-time data. Additionally,  
these types of surveys may lead to misreporting 
and underreporting, especially in contexts where 
there are laws against the practice. Cognisant of 
the highlighted considerations, health facilities 
have a huge potential in filling this gap through 
routine collection of FGM/C data at clinical level. 
This data will not only be crucial in documenting 
the incidence of FGM/C, but will also enhance 
the monitoring of quality of care, provide a rich 
source of data for research, and inform efforts to 
prevent FGM/C and manage complications of 
women and girls living with FGM/C. 
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